3 Terrible Reasons to Buy Monsanto
Before Bayer (NASDAQOTH: BAYRY) arrived onto the scene, I viewed Monsanto (NYSE: MON) as an intriguing growth stock. It has a rich history of delivering value to shareholders and continues to hold a dominant technological edge over key competitors in crop protection products, seeds, and traits. While little has changed its promising pipeline and portfolio,… Read More »